Stay updated on Pembrolizumab in Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Neuroendocrine Tumors Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Updated the page revision from v3.6.2 to v3.6.3, a minor platform update that does not change the displayed study details.
    Difference
    0.1%
    Check dated 2026-07-03T23:23:57.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2, replacing the previous v3.6.0 label. This indicates a minor software update to the page's versioning without altering the study content.
    Difference
    0.1%
    Check dated 2026-06-26T20:00:00.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the recruitment status was updated to No longer looking for participants; the edition label updated to Revision: v3.6.0 and the Intervention/Treatment heading formatting was standardized.
    Difference
    0.5%
    Check dated 2026-06-12T13:29:49.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5, signaling an updated version of the page rendering. This does not reflect changes to the study details or content.
    Difference
    0.1%
    Check dated 2026-06-05T08:35:35.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added and Revision: v3.5.3 was removed, indicating a software version update on the page. The underlying study content and navigation remain unchanged.
    Difference
    0.1%
    Check dated 2026-05-15T02:10:29.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The study record's revision label was updated from v3.5.2 to v3.5.3, indicating a new version of the entry. This update reflects a metadata revision rather than changes to the study content, eligibility, or results.
    Difference
    0.1%
    Check dated 2026-04-30T15:34:10.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Neuroendocrine Tumors Clinical Trial page.